mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.6 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |